July 22, 2022
PAR-22-104 - "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)"
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in PAR-22-104 "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)".
The following sections of PAR-22-104 have been updated (in bold italics) to reflect NHLBI participation in this Funding Opportunity Announcement:
Part 1. Overview Information
Components of Participating Organizations
Fogarty International Center (FIC)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Complementary and Integrative Health (NCCIH)
National Institute on Aging (NIA)
National Heart, Lung, and Blood Institute (NHLBI)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
Office of Research on Women's Health (ORWH)
Assistance Listing Number(s)
93.989, 93.242, 93.213, 93.121, 93.853, 93.313, 93.273, 93.866, 93.840, 93.837, 93.838, 93.839, 93.233
Part 2. Section I. Funding Opportunity Description
Specific Interests of the FOA Sponsors
The National Heart, Lung, and Blood Institute (NHLBI) is interested in training programs that sustainably strengthen heart, lung, blood, and sleep (HLBS) research capacity of low- and middle-income country institutions; train in-country experts to develop and conduct research on HLBS diseases and disorders across the lifespan; and maximize NHLBI’s current global health investments, with the long-range goal of developing and implementing evidence-based, contextualized HLBS interventions to reduce the burden of chronic diseases. Examples of HLBS diseases and disorders include, but are not limited to, hypertension, obesity, rheumatic heart disease, chronic obstructive lung diseases, asthma, and sickle cell disease. Training programs across the spectrum of research disciplines is encouraged, from basic biomedical, behavioral, and social science to clinical and applied sciences, including translational and implementation science that emphasizes the resources, context, and needs of multiple stakeholders in local settings. Training programs should include research skills, research design and methodology, ethics, data management and analysis, grant writing, manuscript writing, scientific presentations and research administration.
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Makeda Williams, Ph.D., M.P.H.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-451-7594
Email:willimak@mail.nih.gov
Grants Management Contact(s)
Kimberly Stanton
National Heart, Lung, and Blood Institute (NHLBI)
Phone: (301) 435-0166
Email:stantonk@nhlbi.nih.gov
All other aspects of the FOA remain unchanged.
Makeda Williams, Ph.D., M.P.H.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-451-7594
Email:willimak@mail.nih.gov